Over 200 pharmacy stakeholder and patient advocacy groups sent a letter to Senators Chuck Grassley and Ron Wyden, chairman and ranking member of the Senate Finance Committee, urging them to include DIR fee reform in their drug pricing legislation. NASPA, along with NCPA, APhA, and many state pharmacy associations, signed on to the letter.
The letter stated: “As CMS itself cited in the proposed rule, DIR fees on pharmacies participating in Part D grew by 45,000 percent between 2010 and 2017. This increase is unacceptable and unsustainable and it creates uncertainty not only for community pharmacies but also for the patients who rely on Part D prescription drugs. Until pharmacy DIR fee reform occurs, seniors will continue to pay higher cost-sharing for their prescription drugs. CMS estimated that these reforms would have saved Medicare beneficiaries between $7.1 and $9.2 billion in cost sharing over the next ten years.”
This letter comes shortly after NCPA’s “Fix DIR Day,” where more than 3,000 emails were sent to senators regarding DIR fee reform.